Noninvasive Monitoring of Reparative Fibrosis after Myocardial Infarction in Rats Using 68Ga-FAPI-04 PET/CT
- PMID: 35969029
- DOI: 10.1021/acs.molpharmaceut.2c00551
Noninvasive Monitoring of Reparative Fibrosis after Myocardial Infarction in Rats Using 68Ga-FAPI-04 PET/CT
Abstract
Noninvasively monitoring activated fibroblasts is of great value for understanding the dynamic process of myocardial fibrosis after myocardial infarction (MI). This study aimed to evaluate the feasibility of 68Ga-labeled fibroblast activation protein inhibitor 04 (68Ga-FAPI-04) for monitoring reparative fibrosis and reactive fibrosis after MI. MI models were prepared by ligation of the left anterior descending (LAD) coronary artery and validated by electrocardiogram and 18F-FDG PET/CT 1 day after MI and hematoxylin and eosin (HE) staining. 68Ga-FAPI-04 PET/CT scans (1, 3, 6, 9, 12, 15, 18, 21, 28, and 35 days after MI) were carried out in MI rats and sham-operated rats without ligation of LAD. Blocking experiments were carried out on MI rats on day 7 after MI with 68Ga-FAPI-04 and excessive FAPI-04. Autoradiography, HE staining, Masson's trichrome staining, and immunofluorescence staining were carried out for ex vivo validation. The infarcted area with decreased or defective myocardial metabolic activity in 18F-FDG PET/CT correspondingly showed high 68Ga-FAPI-04 uptake in the MI rats. The myocardial tracer uptake was significantly different between MI and sham-operated rats from day 1 to 28 after MI and reached peak value 6 days after MI (0.806 ± 0.257%ID/cc vs 0.199 ± 0.012%ID/cc, P < 0.05). Tracer uptake at the infarcted myocardium and normal tissues in MI rats decreased significantly after blocking. Obvious tracer uptake was confirmed by autoradiography, and immunofluorescence staining showed FAP+ cells in the infarcted myocardium and border zone. Masson's trichrome staining of the heart sections of MI rats at different times suggested the presence of myocardial fibrosis. 68Ga-FAPI-04 uptake was not observed in the distal uninjured myocardium throughout the observation period. In conclusion, 68Ga-FAPI-04 PET could noninvasively monitor the activated fibroblasts in the early stage post acute MI and may be helpful for evaluating the degree of reparative fibrosis, while reactive fibrosis monitoring still needs further study.
Keywords: 68Ga-FAPI-04; fibroblast activation protein; myocardial fibrosis; myocardial infarction; positron emission tomography/computed tomography (PET/CT).
Similar articles
-
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04.J Nucl Med. 2019 Dec;60(12):1743-1749. doi: 10.2967/jnumed.119.226993. Epub 2019 Aug 12. J Nucl Med. 2019. PMID: 31405922 Free PMC article.
-
Early detection of radiation-induced myocardial damage by [18F]AlF-NOTA-FAPI-04 PET/CT imaging.Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):453-464. doi: 10.1007/s00259-022-05962-y. Epub 2022 Sep 19. Eur J Nucl Med Mol Imaging. 2023. PMID: 36121463
-
68Ga-FAPI PET visualize heart failure: from mechanism to clinic.Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):475-485. doi: 10.1007/s00259-022-05994-4. Epub 2022 Oct 21. Eur J Nucl Med Mol Imaging. 2023. PMID: 36269382
-
FAPI-Targeted Molecular Imaging: Transforming Insights into Post-Ischemic Myocardial Remodeling?Mol Diagn Ther. 2025 Jul;29(4):435-442. doi: 10.1007/s40291-025-00778-6. Epub 2025 Apr 22. Mol Diagn Ther. 2025. PMID: 40263181 Free PMC article. Review.
-
68Ga-FAPI-04 PET/CT for the Assessment of Light-Chain Cardiac Amyloidosis: A Promising Risk- Stratification Imaging Modality.Curr Cardiol Rep. 2025 Apr 11;27(1):83. doi: 10.1007/s11886-025-02230-x. Curr Cardiol Rep. 2025. PMID: 40214930 Review.
Cited by
-
Toward Quantitative Multisite Preclinical Imaging Studies in Acute Myocardial Infarction: Evaluation of the Immune-Fibrosis Axis.J Nucl Med. 2024 Feb 1;65(2):287-293. doi: 10.2967/jnumed.123.266526. J Nucl Med. 2024. PMID: 38176717 Free PMC article.
-
Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease.Front Nucl Med. 2023 Jul 27;3:1224905. doi: 10.3389/fnume.2023.1224905. eCollection 2023. Front Nucl Med. 2023. PMID: 39355018 Free PMC article. Review.
-
Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases.J Clin Med. 2023 Sep 18;12(18):6033. doi: 10.3390/jcm12186033. J Clin Med. 2023. PMID: 37762974 Free PMC article. Review.
-
Berberin sustained-release nanoparticles were enriched in infarcted rat myocardium and resolved inflammation.J Nanobiotechnology. 2023 Jan 28;21(1):33. doi: 10.1186/s12951-023-01790-w. J Nanobiotechnology. 2023. PMID: 36709291 Free PMC article.
-
Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring.Eur Heart J Cardiovasc Imaging. 2023 Aug 23;24(9):1129-1145. doi: 10.1093/ehjci/jead168. Eur Heart J Cardiovasc Imaging. 2023. PMID: 37467476 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous